scispace - formally typeset
K

Kari Alitalo

Researcher at University of Helsinki

Publications -  844
Citations -  122462

Kari Alitalo is an academic researcher from University of Helsinki. The author has contributed to research in topics: Angiogenesis & Vascular endothelial growth factor C. The author has an hindex of 174, co-authored 817 publications receiving 114231 citations. Previous affiliations of Kari Alitalo include Mount Sinai Hospital, Toronto & Cornell University.

Papers
More filters
Journal ArticleDOI

Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy

TL;DR: Nanoparticles against VEGFR2 and −3 expressing tumor-associated endothelial cells represent a promising and novel anti-cancer strategy that leads to tumor starvation and pronounced reduction of tumor burden.
Journal ArticleDOI

c-Myc and E1A induced cellular sensitivity to activated NK cells involves cytotoxic granules as death effectors.

TL;DR: Evidence is provided that c-Myc and E1A activated the NK cell induced cytolysis at a post-triggering stage of NK cell-target cell interaction, indicating that oncogenes activate the cytotoxicity ofNK cell granules.
Journal ArticleDOI

Transcription Factor PROX1 Suppresses Notch Pathway Activation via the Nucleosome Remodeling and Deacetylase Complex in Colorectal Cancer Stem-like Cells.

TL;DR: It is reported that in LGR5+ colorectal cancer cells, PROX1 suppresses the Notch pathway, which is essential for cell fate in intestinal stem cells and helps to enforce the stem cell phenotype and inhibit differentiation.
Journal ArticleDOI

Short and Long-Term Effects of hVEGF-A165 in Cre-Activated Transgenic Mice

TL;DR: It is concluded that long-term uncontrolled hVEGF-A165 expression in only a limited number of target cells in adult mice can be associated with pathological changes, including possible formation of malignant tumors and uncontrolled bleeding in target tissues.